Modulation of astrocytic metabolic phenotype by proinflammatory cytokines
Open accessThe DOI matches its Crossref record; 12 of the 12 references it cites were found in a registry or an index.
Abstract
Astrocytes play an important role in nervous system homeostasis. In particular, they contribute to the regulation of local energy metabolism and to oxidative stress defence. In previous experiments, we showed that long‐term treatment with interleukin 1α (IL‐1α) or tumor necrosis factor‐α (TNFα) alone increases glucose utilization in primary culture of mouse astrocytes. In our study, we report that a combination of IL‐1β and TNFα exerts a synergistic effect on glucose utilization and markedly modifies the metabolic phenotype of astrocytes. Thus, IL‐1β+TNFα treated astrocytes show a marked decrease in glycogen levels, a slight but not significant decrease in lactate release as well as a massive increase in both the pentose phosphate pathway and TCA cycle activities. Glutamate‐stimulated glucose utilization and lactate release, a typical feature of astrocyte energy metabolism, are altered after pretreatment with IL‐1β+TNFα. As far as mechanisms for oxidative stress defence are concerned, we observed that treatment with IL‐1β+TNFα decreases cellular glutathione content and increases glutathione release into the extracellular space while stimulating superoxide anion and nitric oxide production as well as H 2 O 2 release. Interestingly, stimulation of glucose utilization by IL‐1β+TNFα is not affected by the antioxidant N‐acetyl‐L‐cysteine, suggesting that cellular stress does not account for this effect. Finally, the effects of cytokines on glucose utilization appear to involve multiple signaling cascades including the phosphoinositide 3‐kinase and mitogen‐activated protein kinases. Taken together these results establish that a proinflammatory environment such as observed in several neuropathological conditions including Alzheimer's disease, markedly modifies the metabolic phenotype of astrocytes. © 2008 Wiley‐Liss, Inc.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
The NOX Family of ROS-Generating NADPH Oxidases: Physiology and Pathophysiology
Bedard, K., & Krause, K.-H. (2007) · Physiological Reviews · doi:10.1152/physrev.00044.2005 · Cited by 6,989
Pellerin, L., & Magistretti, P. J. (1994) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.91.22.10625 · Cited by 2,927
Oxidative stress and neurodegeneration: where are we now?
Halliwell, B. (2006) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2006.03907.x · Cited by 2,614 · cited 3×
“Oxidative stress is a key feature of inflammatory processes and neurodegeneration (Halliwell, 2006) and occurs as a consequence of disequilibrium between the production of ROS and antioxidant processes leading to excess of ROS.”
BackgroundMetabolism and functions of glutathione in brain
Dringen, R. (2000) · Progress in Neurobiology · doi:10.1016/s0301-0082(99)00060-x · Cited by 1,702
The role of inflammation in CNS injury and disease
Lucas, S., Rothwell, N. J., & Gibson, R. M. (2006) · British Journal of Pharmacology · doi:10.1038/sj.bjp.0706400 · Cited by 1,272 · cited 4×
“…and have been implicated in the pathogenesis of several neuropathological conditions such as in stroke, traumatic brain injury, epilepsy, infection, and neurodegenerative diseases such as multiple sclerosis, Parkinson’s disease or Alzheimer’s disease (Allan and Rothwell, 2001; Lucas et al., 2006).”
BackgroundInfluentialBak, L. K., Schousboe, A., & Waagepetersen, H. S. (2006) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2006.03913.x · Cited by 1,114
Interleukin-1 and neuronal injury
Allan, S. M., Tyrrell, P. J., & Rothwell, N. J. (2005) · Nature Reviews Immunology · doi:10.1038/nri1664 · Cited by 992 · cited 1×
“Since IL-1b appears to play the major role in the brain and in neurodegeneration (Allan et al., 2005; Basu et al., 2004), this cytokine has been used for subsequent experiments.”
Method“Inflammatory” Cytokines: Neuromodulators in Normal Brain?
Vitkovic, L., Bockaert, J., & Jacque, C. (2000) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.2000.740457.x · Cited by 506 · cited 1×
“It is now widely established that cytokines are expressed also in the brain and participate in numerous physiological and pathological processes (Vitkovic et al., 2000).”
BackgroundSelective distribution of lactate dehydrogenase isoenzymes in neurons and astrocytes of human brain
Bittar, P. G., Charnay, Y., Pellerin, L., Bouras, C., & Magistretti, P. J. (1996) · Journal of Cerebral Blood Flow & Metabolism · doi:10.1097/00004647-199611000-00001 · Cited by 423 · cited 3×
“2003), the so-called astrocyte-neuron lactate shuttle (Bittar et al., 1996) has been challenged on theoretical grounds by certain authors (Chih and Roberts, 2003;”
BackgroundSelf-citationNeuronal-glial glucose oxidation and glutamatergic-GABAergic function.
Hyder, F., Patel, A. B., Gjedde, A., Rothman, D. L., Behar, K. L., & Shulman, R. G. (2006) · Journal of Cerebral Blood Flow & Metabolism · doi:10.1038/sj.jcbfm.9600263 · Cited by 408 · cited 2×
“Moreover, lactate released by astrocytes, as proposed by the astrocyte-neuron lactate shuttle model (Hyder et al., 2006; Magistretti et al., 1999), has been shown to represent an energy substrate readily accessible to neurons to sustain their metabolic needs (Schurr, 2006; Schurr et al., 1988).”
Background
Cited by
Inflammation and Its Discontents: The Role of Cytokines in the Pathophysiology of Major Depression
Miller, A. H., Maletic, V., & Raison, C. L. (2009) · Biological Psychiatry · doi:10.1016/j.biopsych.2008.11.029 · Cited by 3,848
“species that in combination with QUIN (see above) can amplify oxidative stress and further endanger relevant cell types, including neurons and oligodendrocytes, which are especially vulnerable to oxidative damage (36,40,69,70,73,75-77,83).”
Neuron-glia metabolic coupling and plasticity
Magistretti, P. J. (2011) · Experimental Physiology · doi:10.1113/expphysiol.2010.053157 · Cited by 747
Self-citationMethylglyoxal, the dark side of glycolysis
Allaman, I., Bélanger, M., & Magistretti, P. J. (2015) · Frontiers in Neuroscience · doi:10.3389/fnins.2015.00023 · Cited by 547
Self-citationNeurobiology of depression, fibromyalgia and neuropathic pain
Maletic, V. (2009) · Frontiers in Bioscience · doi:10.2741/3598 · Cited by 366
The Role of Astrocytes in Multiple Sclerosis
Ponath, G., Park, C., & Pitt, D. (2018) · Frontiers in Immunology · doi:10.3389/fimmu.2018.00217 · Cited by 359
Buffo, A., Rolando, C., & Ceruti, S. (2010) · Biochemical Pharmacology · doi:10.1016/j.bcp.2009.09.014 · Cited by 321
Allaman, I., Gavillet, M., Bélanger, M., Laroche, T., Viertl, D., Lashuel, H. A., & Magistretti, P. J. (2010) · The Journal of Neuroscience · doi:10.1523/jneurosci.5098-09.2010 · Cited by 278
Self-citationFalkowska, A., Gutowska, I., Goschorska, M., Nowacki, P., Chlubek, D., & Baranowska-Bosiacka, I. (2015) · International Journal of Molecular Sciences · doi:10.3390/ijms161125939 · Cited by 277
The Concept of Depression as a Dysfunction of the Immune System
E. Leonard, B. (2010) · Current Immunology Reviews · doi:10.2174/157339510791823835 · Cited by 276
Questions and (some) answers on reactive astrocytes
Escartin, C., Guillemaud, O., & Carrillo‐de Sauvage, M. (2019) · Glia · doi:10.1002/glia.23687 · Cited by 275
Astrocytes: Integrative Regulators of Neuroinflammation in Stroke and Other Neurological Diseases
Cekanaviciute, E., & Buckwalter, M. S. (2016) · Neurotherapeutics · doi:10.1007/s13311-016-0477-8 · Cited by 229
“Both glutamate and the proinflammatory cytokines IFN-γ, IL-1β, IL-6, and TNF-α are sufficient to increase glucose utilization in astrocyte cultures, while the antiinflammatory cytokines IL-4 and IL-10 to reduce glucose utilization [96, 159].”
BackgroundThe energetic brain—A review from students to students
Bordone, M. P., Salman, M. M., Titus, H. E., Amini, E., Andersen, J. V., Chakraborti, B., Diuba, A. V., Dubouskaya, T. G., Ehrke, E., Espindola de Freitas, A., et al. (2019) · Journal of Neurochemistry · doi:10.1111/jnc.14829 · Cited by 205
“Additionally, glucose is used by neurons to restore reducing equivalents of reduced nicotinamide adenine dinucleotide phosphate (NADPH) used in glutathione regeneration via the PPP which cannot be fueled by lactate (Gavillet et al. 2008; Bola~nos et al. 2010).”
MethodThe Glutathione System in Parkinson’s Disease and Its Progression
Bjørklund, G., Peana, M., Maes, M., Dadar, M., & Severin, B. (2021) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2020.10.004 · Cited by 186
The role of depressive subtypes within the neuroinflammation hypothesis of major depressive disorder
Woelfer, M., Kasties, V., Kahlfuss, S., & Walter, M. (2019) · Neuroscience · doi:10.1016/j.neuroscience.2018.03.034 · Cited by 171
X13CMS: Global Tracking of Isotopic Labels in Untargeted Metabolomics
Huang, X., Chen, Y.-J., Cho, K., Nikolskiy, I., Crawford, P. A., & Patti, G. J. (2014) · Analytical Chemistry · doi:10.1021/ac403384n · Cited by 159
Integrative neurobiology of metabolic diseases, neuroinflammation, and neurodegeneration
van Dijk, G., van Heijningen, S., Reijne, A. C., Nyakas, C., van der Zee, E. A., & Eisel, U. L. M. (2015) · Frontiers in Neuroscience · doi:10.3389/fnins.2015.00173 · Cited by 75
Calì, C., Cantando, I., Veloz Castillo, M. F., Gonzalez, L., & Bezzi, P. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms25168922 · Cited by 66
Sen, Z. D., Danyeli, L. V., Woelfer, M., Lamers, F., Wagner, G., Sobanski, T., & Walter, M. (2021) · Brain, Behavior, and Immunity · doi:10.1016/j.bbi.2020.12.020 · Cited by 65
Taïb, B., Bouyakdan, K., Hryhorczuk, C., Rodaros, D., Fulton, S., & Alquier, T. (2013) · Journal of Biological Chemistry · doi:10.1074/jbc.m113.506238 · Cited by 65
Cardoner, N., Andero, R., Cano, M., Marin-Blasco, I., Porta-Casteràs, D., Serra-Blasco, M., Via, E., Vicent-Gil, M., & Portella, M. J. (2024) · Current Neuropharmacology · doi:10.2174/1570159x21666230703091435 · Cited by 45
“Pro-inflammatory cytokines can also induce the release of reactive oxygen species by astrocytes and microglia promoting neuronal oxidative damage [108, 109].”
BackgroundAstrocytes and Microglia in Stress-Induced Neuroinflammation: The African Perspective
Olude, M. A., Mouihate, A., Mustapha, O. A., Farina, C., Quintana, F. J., & Olopade, J. O. (2022) · Frontiers in Immunology · doi:10.3389/fimmu.2022.795089 · Cited by 37
“Furthermore, astrocytes can provide metabolic precursors of glutamate back to the neurons through monocarboxylate transporters (MCT), thus satisfying neuronal metabolic needs and limiting novel neurotransmitter synthesis (15, 16) Though scarce information is available about astrocyte metabolism in neuroinflammatory mo…”
BackgroundClozapine induces astrocyte-dependent FDG-PET hypometabolism
Rocha, A., Bellaver, B., Souza, D. G., Schu, G., Fontana, I. C., Venturin, G. T., Greggio, S., Fontella, F. U., Schiavenin, M. L., Machado, L. S., et al. (2022) · European Journal of Nuclear Medicine and Molecular Imaging · doi:10.1007/s00259-022-05682-3 · Cited by 31
Apolipoprotein E ε4 modulates astrocyte neuronal support functions in the presence of amyloid‐β
Fleeman, R. M., Kuhn, M. K., Chan, D. C., & Proctor, E. A. (2023) · Journal of Neurochemistry · doi:10.1111/jnc.15781 · Cited by 20
Zimmer, E. R., Pascoal, T. A., Rosa-Neto, P., Nordberg, A., & Pellerin, L. (2022) · Science Translational Medicine · doi:10.1126/scitranslmed.abm8302 · Cited by 17
“In parallel, it was previously shown that IL-1, IL-1, and TNF enhance glucose uptake by astrocytes (9).”
Background
Metadata
- Authors
- Gavillet, M., Allaman, I., & Magistretti, P. J.
- Venue
- Glia
- Publisher
- Wiley
- Published
- 2008-03-27
- Volume
- 56
- Issue
- 9
- Pages
- 975-989
- ISSN
- 0894-1491 (ISSN-L)
- 1098-1136
- OpenAlex
- W2019078591
- Cited by
- 149
- References
- 12
- FWCI
- 4.31
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.